Mayo Clinic and collaborators find new class of drugs that reduces aging in mice

James L. Kirkland, M.D., Ph.D., discusses a study finding a new class of drugs, identified and validated by Mayo Clinic researchers and their collaborators, clearly reduces health problems in mice by limiting the effect of senescent cells.

Mayo Clinic study of thousands of brains reveals tau as driver of Alzheimer's disease

By examining more than 3,600 postmortem brains, researchers at Mayo Clinic have found that the progression of dysfunctional tau protein drives the cognitive decline and memory loss seen in Alzheimer's disease.

Study Suggests Acutely Injured Kidneys can be Considered for Transplant

Research suggests that some acutely injured kidneys from donors who are deceased can be used for transplant with safe, positive outcomes.

Mayo Clinic researcher on factors to improve breast cancer risk prediction

Mayo Clinic researcher Fergus J. Couch, Ph.D., discusses a study show that combined 77 common genetic variants into a single risk factor that can be used to improve the identification of women with an elevated risk of breast cancer.

Researchers locate master cutoff switch for cancer-causing HER2 protein

Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein.

Advancing the knowledge of ALS and FTD

Researchers at Mayo Clinic's campus in Florida have developed a mouse model that exhibits the features associated with the most common genetic form of ALS and frontotemporal dementia.